[go: up one dir, main page]

ES2159489A1 - Nuevos derivados de imidazol con actividad antiinflamatoria. - Google Patents

Nuevos derivados de imidazol con actividad antiinflamatoria.

Info

Publication number
ES2159489A1
ES2159489A1 ES200000707A ES200000707A ES2159489A1 ES 2159489 A1 ES2159489 A1 ES 2159489A1 ES 200000707 A ES200000707 A ES 200000707A ES 200000707 A ES200000707 A ES 200000707A ES 2159489 A1 ES2159489 A1 ES 2159489A1
Authority
ES
Spain
Prior art keywords
imidazole derivatives
inflammatory activity
novel imidazole
novel
prodrugs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES200000707A
Other languages
English (en)
Other versions
ES2159489B1 (es
Inventor
Carmen Almansa
Concepcion Gonzalez
M Carmen Torres
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Noucor Health SA
Original Assignee
J Uriach y Cia SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by J Uriach y Cia SA filed Critical J Uriach y Cia SA
Priority to ES200000707A priority Critical patent/ES2159489B1/es
Priority to ARP010101304A priority patent/AR028270A1/es
Priority to MXPA02009322A priority patent/MXPA02009322A/es
Priority to BR0109445-9A priority patent/BR0109445A/pt
Priority to AU2001239311A priority patent/AU2001239311A1/en
Priority to JP2001568914A priority patent/JP2003528086A/ja
Priority to CA002403732A priority patent/CA2403732A1/en
Priority to KR1020027012555A priority patent/KR20020087942A/ko
Priority to PCT/ES2001/000114 priority patent/WO2001070704A1/es
Priority to US10/239,359 priority patent/US6743816B2/en
Priority to EP01913898A priority patent/EP1270559A1/en
Publication of ES2159489A1 publication Critical patent/ES2159489A1/es
Application granted granted Critical
Publication of ES2159489B1 publication Critical patent/ES2159489B1/es
Priority to NO20024504A priority patent/NO20024504L/no
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/68—Halogen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Reproductive Health (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Nuevos derivados de imidazol con actividad antiinflamatoria. Nuevos derivados de imidazol de fórmula I y sus sales, solvatos y prodrogas, en donde los significados de los distintos radicales son como se han indicado en la parte descriptiva. Dichos compuestos son útiles como antiinflamatorios.
ES200000707A 2000-03-23 2000-03-23 Nuevos derivados de imidazol con actividad antiinflamatoria. Expired - Fee Related ES2159489B1 (es)

Priority Applications (12)

Application Number Priority Date Filing Date Title
ES200000707A ES2159489B1 (es) 2000-03-23 2000-03-23 Nuevos derivados de imidazol con actividad antiinflamatoria.
ARP010101304A AR028270A1 (es) 2000-03-23 2001-03-20 Un compuesto que comprende derivados de imidazol con actividad antiinflamatoria y el procedimiento para preparar el mismo
US10/239,359 US6743816B2 (en) 2000-03-23 2001-03-22 Imidazole derivatives with anti-inflammatory activity
AU2001239311A AU2001239311A1 (en) 2000-03-23 2001-03-22 Novel imidazole derivatives with anti-inflammatory activity
JP2001568914A JP2003528086A (ja) 2000-03-23 2001-03-22 抗炎症活性を有する新規イミダゾール誘導体
CA002403732A CA2403732A1 (en) 2000-03-23 2001-03-22 Novel imidazole derivatives with anti-inflammatory activity
MXPA02009322A MXPA02009322A (es) 2000-03-23 2001-03-22 Nuevos derivados de imidazol con actividad antiinflamatoria.
PCT/ES2001/000114 WO2001070704A1 (es) 2000-03-23 2001-03-22 Nuevos derivados de imidazol con actividad antiinflamatoria
BR0109445-9A BR0109445A (pt) 2000-03-23 2001-03-22 Derivados de imidazol com atividade antiinflamatória
EP01913898A EP1270559A1 (en) 2000-03-23 2001-03-22 Novel imidazole derivatives with anti-inflammatory activity
KR1020027012555A KR20020087942A (ko) 2000-03-23 2001-03-22 항염증 활성이 있는 신규 이미다졸 유도체
NO20024504A NO20024504L (no) 2000-03-23 2002-09-20 Nye imidazolderivater med anti-inflammatorisk aktivitet

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200000707A ES2159489B1 (es) 2000-03-23 2000-03-23 Nuevos derivados de imidazol con actividad antiinflamatoria.

Publications (2)

Publication Number Publication Date
ES2159489A1 true ES2159489A1 (es) 2001-10-01
ES2159489B1 ES2159489B1 (es) 2002-04-16

Family

ID=8492829

Family Applications (1)

Application Number Title Priority Date Filing Date
ES200000707A Expired - Fee Related ES2159489B1 (es) 2000-03-23 2000-03-23 Nuevos derivados de imidazol con actividad antiinflamatoria.

Country Status (12)

Country Link
US (1) US6743816B2 (es)
EP (1) EP1270559A1 (es)
JP (1) JP2003528086A (es)
KR (1) KR20020087942A (es)
AR (1) AR028270A1 (es)
AU (1) AU2001239311A1 (es)
BR (1) BR0109445A (es)
CA (1) CA2403732A1 (es)
ES (1) ES2159489B1 (es)
MX (1) MXPA02009322A (es)
NO (1) NO20024504L (es)
WO (1) WO2001070704A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2184633B1 (es) * 2001-08-07 2004-08-01 J. URIACH & CIA, S.A. Procedimiento para la preparacion de derivados de 4-(imidazol-1-il) bencenosulfonamida.
GB0225548D0 (en) 2002-11-01 2002-12-11 Glaxo Group Ltd Compounds
GB0306329D0 (en) * 2003-03-19 2003-04-23 Glaxo Group Ltd Compounds
GB0323585D0 (en) * 2003-10-08 2003-11-12 Glaxo Group Ltd Compounds
CN102464652B (zh) * 2010-11-02 2013-08-28 北京欧博方医药科技有限公司 咪唑衍生物、制备方法及用途
CN104926797B (zh) * 2014-06-10 2019-04-16 北京元博方医药科技有限公司 呋喃酮衍生物、制备方法及用途

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3901908A (en) * 1970-12-28 1975-08-26 Ciba Geigy Corp 2-alkyl- and 2-cycloalkyl-4,5-bis-phenyl-imidazoles
EP0074130A2 (en) * 1981-07-31 1983-03-16 ZAMBON S.p.A. New imidazole compounds, process for the preparation thereof and pharmaceutical compositions containing them
WO1996003388A1 (en) * 1994-07-28 1996-02-08 G.D. Searle & Co. 1,2-substituted imidazolyl compounds for the treatment of inflammation
WO1996003387A1 (en) * 1994-07-28 1996-02-08 G.D. Searle & Co. 4,5-substituted imidazolyl compounds for the treatment of inflammation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR024222A1 (es) 1998-10-16 2002-09-25 Palau Pharma Sa Imidazoles con actividad antiinflamatoria un procedimiento para su preparacion y composiciones farmaceuticas que lo contienen

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3901908A (en) * 1970-12-28 1975-08-26 Ciba Geigy Corp 2-alkyl- and 2-cycloalkyl-4,5-bis-phenyl-imidazoles
EP0074130A2 (en) * 1981-07-31 1983-03-16 ZAMBON S.p.A. New imidazole compounds, process for the preparation thereof and pharmaceutical compositions containing them
WO1996003388A1 (en) * 1994-07-28 1996-02-08 G.D. Searle & Co. 1,2-substituted imidazolyl compounds for the treatment of inflammation
WO1996003387A1 (en) * 1994-07-28 1996-02-08 G.D. Searle & Co. 4,5-substituted imidazolyl compounds for the treatment of inflammation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
KHANNA, I.K. y col. 1,2-Diarylimidazoles as Potent, Cyclooxigenase-2 Selective, and Orally Active Antiinflammatory Agents. J. Med. Chem., 1997, Vol. 40, paginas 1634-1647, todo el documento. *

Also Published As

Publication number Publication date
US6743816B2 (en) 2004-06-01
BR0109445A (pt) 2003-06-03
NO20024504D0 (no) 2002-09-20
ES2159489B1 (es) 2002-04-16
US20030176481A1 (en) 2003-09-18
CA2403732A1 (en) 2002-09-20
AR028270A1 (es) 2003-04-30
WO2001070704A1 (es) 2001-09-27
MXPA02009322A (es) 2003-03-12
NO20024504L (no) 2002-11-22
JP2003528086A (ja) 2003-09-24
EP1270559A1 (en) 2003-01-02
AU2001239311A1 (en) 2001-10-03
KR20020087942A (ko) 2002-11-23

Similar Documents

Publication Publication Date Title
AU2002246728A1 (en) Carboline derivatives
PT1140944E (pt) Derivados de epotilona e sua utilizacao como agentes antitumorais
SE9900100D0 (sv) New compounds
GB9801690D0 (en) Therapeutic agents
MXPA02011977A (es) Herbicidas de piridina sustituidas.
TW200504061A (en) Pyrazolopyridine derivatives
BG106586A (en) Pyrazolopyramidines as therapeutic agents
BG108268A (en) Pyrazolopyrimidines as therapeutic agents
MXPA04001685A (es) Derivados de sulfonilamino empleados como herbicida.
AU2002249890A1 (en) Carboline derivatives
ATE258930T1 (de) Dihydrobenzifurane
DK1313740T3 (da) Prodrugs af imidazopyridinderivater
CA2395186A1 (en) Procollagen c-proteinase inhibitors
ATE302772T1 (de) 2-(1h-indol-3-yl)-2-oxo-acetamide mit antitumoraler wirkung
TR200201128T2 (tr) PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri.
AP2002002466A0 (en) 3-heterocycliylpropanohydroxamic acid PCP INHIBITORS.
ATE259813T1 (de) Triazolopyrimidinderivate
ES2159489A1 (es) Nuevos derivados de imidazol con actividad antiinflamatoria.
MXPA03003942A (es) Compuestos bis-heterociclicos con actividad antitumoral y quimiosensibilizante.
ATE330958T1 (de) Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate
AU2002223796A1 (en) Pleuromutilin derivatives with antimicrobial activity
MXPA03003971A (es) Derivados de indol como inhibidores de pde5.
HRP20010885B1 (en) Ethanesulfonyl-piperidine derivatives
MXPA05006957A (es) Nuevos derivados de fosforamida.
TR200200017T2 (tr) Benzofuran türevleri

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20010120

Kind code of ref document: A1

Effective date: 20010120

FD1A Patent lapsed

Effective date: 20100312